Clinical trial
Enoxaparin in Acute Venous Thromboembolic Disease
NCT00265993 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00265993 |
|---|---|
| Title | Enoxaparin in Acute Venous Thromboembolic Disease |
| Official title | The Efficacy of Subcutaneous Enoxaparin Once Daily in the Treatment of Acute Venous Thromboembolic Disease: an Open-labelled, Non-comparative, Multicentric, Phase IV Trial |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Venous Thrombosis |
| Intervention type | Drug |
| Interventions | enoxaparin |
| Enrollment | 251 |
| Start date | Dec 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Dec 15, 2005 |
| Last update posted | Feb 3, 2010 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: